Diagnosing tuberculosis in patients with HIV: Do we know enough?

American Journal of Respiratory and Critical Care Medicine

Volumn 180, Issue 9, 2009, Pages 800-801

  Perlman, David C ^a   Chi, Chiu Leung ^b   Wing, Wai Yew ^c  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b DEPARTMENT OF HEALTH   (Hong Kong)

^c GRANTHAM HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM CULTURE; CULTURE TECHNIQUE; DIAGNOSTIC VALUE; EDITORIAL; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LUNG TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM; PRIORITY JOURNAL; SPUTUM CYTODIAGNOSIS;

BACTERIOLOGICAL TECHNIQUES; HIV INFECTIONS; HUMANS; LYMPH NODES; MYCOBACTERIUM; SPUTUM; THAILAND; TUBERCULOSIS; VIETNAM;

EID: 70350446685     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200908-1226ED     Document Type: Editorial

References (14)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing WHO report 2009. Geneva, Switzerland: WHO; 2009.
2. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-1580. (Pubitemid 44780738)
3. Monkongdee P, McCarthy KD, Cain KP, Tasaneeyapan T, Dung NH, Lan NTN, Yen NTB, Teeratakulpisarn N, Udomsantisuk N, Heilig C, et al. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med. 2009;180:903-908.
4. WHO Strategic and Technical Advisory Group for Tuberculosis. Report on conclusions and recommendations, 11-13 June, 2007, WHO, Geneva, Switzerland [accessed August 5, 2009]. Available from: http://www.who.int/tb/events/stag- report-2007.pdf.
5. Loudon RG, Williamson J, Johnson JM. An analysis of 3,485 tuberculosis contacts in the city of Edinburgh during 1954-1955. Am Rev Tuberc 1958;77:623-643.
6. Tostmann A, Kik SV, Kalisvaart NA, Sebek MM, Verver S, Boeree MJ, van Soolingen D. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in The Netherlands. Clin Infect Dis 2008;47:1135-1142.
7. WHO. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: recommendations for HIV-prevalent and resource-constrained settings. Geneva, Switzerland: WHO; 2007.
8. Srisuwanvilai LO, Monkongdee P, Podewils LJ, Ngamlert K, Pobkeeree V, Puripokai P, Kanjanamongkolsiri P, Subhachaturas W, Akarasewi P, Wells CD, et al. Performance of the BACTEC MGIT 960 compared with solid media for detection of Mycobacterium in Bangkok, Thailand. Diagn Microbiol Infect Dis 2008;61:402-407. (Pubitemid 351982001)
9. Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, et al.; Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Epidemiology of antituberculosis drug resistance 2002-2007: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 2009;373:1861-1873.
10. Leung CC, Chang KC. Role of interferon gamma release assays in tuberculosis. Respirology 2009;14:156-158.
11. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008;177:787-792.
12. WHO. Policy statement: molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis, WHO June 27 2008 [accessed August 5, 2009]. Available from: http://www.who.int/tb/features- archive/policy-statement.pdf.
13. WHO. Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. Geneva, Switzerland: WHO; 2008.
14. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Piñedo Y, Saravia JC, Salazar C, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006;355:1539-1550.